Detalles de la búsqueda
1.
Cost-Effectiveness of the Dabrafenib Schedule in Combination With Trametinib Compared With Other Targeted Therapies, Immunotherapy, and Dacarbazine for the Treatment of Unresectable or Metastatic Melanoma With BRAFV600 Mutation in Colombia.
Value Health Reg Issues
; 26: 182-190, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34673349
Resultados
1 -
1
de 1
1
Próxima >
>>